Stock market news for October 26, 2026. Press releases, financial news, and business developments from public companies with ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Boston Scientific (BSX) with bullish sentiments. According to TipRanks.com, CFA is a ...
Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report third quarter 2026 financial results on Monday, ...
The new Kidney Care National Plan from the US Department of Health and Human Services focuses on preventing kidney failure, ...
MedPage Today on MSN
Trio of IgA nephropathy drugs proves mettle in interim analyses
Significant proteinuria reductions reported, but still awaiting eGFR data ...
Travere Therapeutics reported durable biomarker data for FILSPARI in IgA nephropathy, but shares fell 4.5% as markets focus ...
Travere Therapeutics, Inc. (Nasdaq: TVTX) today presented new biomarker data from the Phase 3 PROTECT Study providing ...
Travere Therapeutics presented Phase 3 PROTECT biomarker findings suggesting FILSPARI may modify underlying disease ...
Travere (TVTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...
With a late Thursday nod from the FDA to reduce protein levels in the urine of patients with primary immunoglobulin A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results